Navigation Links
VaxGen Addresses MPM Claims in Letter to Stockholders
Date:12/20/2007

no value in an asset liquidation scenario. By contrast, VaxGen's remaining NOLs, and indeed, Raven's NOLs, will accrue to the combined company, so to the extent that they are valuable to a potential future acquiror, that value has been increased and will remain an asset.

Turning to the liability side of the calculation, MPM fails in its letter to address significant obligations and liabilities that VaxGen would be required to resolve, beyond the repayment of the outstanding $31.5 million convertible debt. For example, VaxGen has a lease obligation totaling over $25 million through 2016. A negotiated lease termination or securing a sub-lease agreement would likely involve significant cost to VaxGen under a liquidation scenario. Severance and other legal and wind-down expenses associated with liquidation would also result in costs to the company easily in excess of $5 million.

On the topic of the bridge loan, VaxGen's agreement with Raven provides that, prior to stockholder vote and close of the merger, Raven will be funded by a combination of Raven Series D stockholder investment and VaxGen, in the form of a bridge loan. VaxGen felt that extending such funding would ensure that Raven's critical clinical and non-clinical development activities could proceed prior to close. The provisions and terms of the bridge loan were heavily negotiated in the context of the overall deal. MPM has incorrectly characterized the bridge as "a non-recourse loan." The loan is forgiven if the merger is approved by the stockholders, and VaxGen and its stockholders stand to benefit by the advancement of Raven's portfolio. If the merger is not approved, the loan, in its entirety, is repayable with interest and is secured by Raven's significant intellectual property assets.

MPM has requested that VaxGen violate its merger agreement by withholding funding of the bridge loan. This is not feasible without significant consequences. Should Vaxgen seek to terminate, or willful
'/>"/>

SOURCE VaxGen
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. VaxGen Files 2006 Financial Statements and Provides Cash Update
2. VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
3. VaxGen Files First Quarter 2007 Financials
4. Jack Anthony to Resign From VaxGens Board After Accepting CEO Position at Osprey Pharmaceuticals
5. VaxGen Files Last Outstanding Periodic Report With SEC
6. Free White Paper Addresses Challenges of New FDA Regulations Awaiting Combo Product Manufacturers
7. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
8. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
9. Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics
10. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
11. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... YORK , May 21, 2013  The Lindsley F. ... today that it is a Grand Challenges Explorations ... Gates Foundation .  Dr. Sara Lustigman , ... innovative global health and development research project, titled Innovative ...  These worms are needed to screen drugs to help ...
(Date:5/21/2013)... May 21, 2013 Through science fairs, ... funds for lab equipment, 25 organizations will continue their ... of optics and photonics in daily life with the ... The organizations, located in 10 countries, are the first ... awarded by SPIE, the international society for optics ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Alpha ... distributor , will be exhibiting for the 13th ... of Medical Instrumentation (AAMI) 2013 Conference and Expo. ... support, distribute, and manufacture healthcare technologies. This year’s ... Long Beach, California. , The three-day event ...
(Date:5/21/2013)... Savoury Systems International (SSI), a leader ... to Southeastern USA Sales Broker. Braddy’s new role will ... the Southeast. , In 2004 Braddy founded ... to food processors and industrial manufacturers. Braddy has ... industry and has over 25 years of sales management ...
Breaking Biology Technology:New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 2New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 3Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2
... 10% of all sales ... to be donated to ALSF, ... Tastykake snack line, today announced the re-issue,of Alex,s Lemon Krimpets(R) and ... nation,s leading organizations in the,fight against childhood cancer. Named for Alexandra ...
... 4, 2008 Scientists in fields,as diverse as ... the Olympus FluoroPoint(TM) single molecule fluorescence,detection system for ... laboratories around the world, the system, with its ... use, is now,available for the first time to ...
... Professionals and Addressing the ... Issues Facing Clinical Labs Worldwide, ABBOTT PARK, Ill., April ... support of an initiative to,raise international awareness of the role ... contribution to improve,patient outcomes. Through a program called Labs Are ...
Cached Biology Technology:Tasty Baking Company Continues Partnership With Alex's Lemonade Stand Foundation To Fight Childhood Cancer 2Olympus FluoroPoint(TM) System Provides High-Sensitivity Single Molecule and Protein Interaction Analysis for Screening and Research 2Olympus FluoroPoint(TM) System Provides High-Sensitivity Single Molecule and Protein Interaction Analysis for Screening and Research 3International Federation of Clinical Chemistry Forms Partnership With the Labs Are Vital(TM) Initiative 2International Federation of Clinical Chemistry Forms Partnership With the Labs Are Vital(TM) Initiative 3
(Date:5/21/2013)... at USC have found that a class of pharmaceuticals ... , The drugs, known as "TSPO ligands," are ... looked at the effects of TSPO ligand in young ... and in aged mice when pathology was quite severe," ... School of Gerontology. "TSPO ligand reduced measures of pathology ...
(Date:5/21/2013)... of Illinois at Chicago College of Medicine will study gender ... its main energy source -- and how changes in fat ... $2 million, 4-year grant from the National Heart, Lung and ... uses fuel for energy. These changes may play a major ... in men and women, says E. Douglas Lewandowski, director of ...
(Date:5/21/2013)... path of insulin action in cells in precise detail ... understanding what goes wrong in diabetes. , The ... James from Sydney,s Garvan Institute of Medical Research, is ... prestigious journal Cell Metabolism . , First discovered ... role in the body because it helps us lower ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2Do men's and women's hearts burn fuel differently? 2Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3
... substances in our most common medicines are manufactured in ... drugs to the environment. Swedish scientists now show that ... of antibiotics. International experts fear that this may contribute ... Using a novel method, based on large-scale DNA sequencing, ...
... conservation strategies may better protect mammals from human ... small populations, a study finds. Charles Yackulic and ... species to find patterns that might help conservationists ... According to the authors, an animal,s habitable range ...
... to join the American Society for Nutrition (ASN) this ... and Controversies in Clinical Nutrition Conference. As the leading ... both sides of controversial nutrition topics in dietary supplements, ... and science writers and bloggers, are invited to attend ...
Cached Biology News:Pollution with antibiotics leads to resistant bacteria 2
PCR purification kit, 100 preps...
The BD PhosFlow Fix Buffer I can be used for the simultaneous fixation and permeabilization of cells prior to intracellular staining. Applications: Intracellular Staining (Flow) Storage Temperature:...
Rabbit polyclonal to 3-Ethynylestradiol ( Abpromise for all tested applications). Antigen: Ethynylestradiol conjugated to BSA....
Request Info...
Biology Products: